Further, ATRX loss was significantly associated with DRG2 downregulation in several other tumour types which are frequently ALT-positive, such as HGG, osteosarcoma, paraganglioma, and phaeochromocytoma (Supplementary Fig. S4A). This evidence concerns the gene ATRX and paraganglioma.